1. Determine how to implement current screening recommendations for glaucoma in their practice.
2. Determine when diagnostic findings indicate that patients should be referred to an ophthalmologist or optometrist for evaluation for glaucoma.
3. Monitor patients receiving medical treatment for open-angle glaucoma for side effects and conditions that may affect treatment.
4. Initiate therapy to lower intraocular pressure in patients with acute angle-closure glaucoma until they can be seen by an ophthalmologist.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
David T. Walsworth, MD, FAAFP, Chair, Associate Chair for Clinical Affairs and Associate Professor, Department of Family Medicine, College of Human Medicine, Michigan State University
B. Wayne Blount, MD, MPH, FAAFP, Medical Director, JenCare; Professor, Department of Family Medicine, Emory University School of Medicine, Atlanta
- 0.50 AAFP prescribed